Tag: Fda boxed warning

In 2020, the U.S. Food and Drug Administration (FDA) issued a boxed warning for Singulair (montelukast) due to the serious neuropsychiatric risks, which made it clear that understanding what are the side effects of singulair is crucial for both patients and healthcare providers. This guide provides a comprehensive overview of the potential effects of this medication.

Montelukast, the generic name for the brand-name drug Singulair, is a prescription medication that blocks leukotrienes, which are inflammatory chemicals released by the body. Knowing **what is Singulair used for** is crucial, as it is a controller medication for certain conditions and not a rescue treatment for acute attacks.

In 2016, the FDA updated its warnings for oral and injectable fluoroquinolone antibiotics, including ciprofloxacin, citing the risk of disabling and potentially permanent side effects. Understanding what are the side effects of ciprofloxacin for UTI is therefore critical for anyone considering this medication.